Clinical value of simultaneous detection of anti-dsDNA and anti-chromatin antibodies using a multiplex immunoassay in systemic lupus erythematosus: a 5-year retrospective study.

Fiche publication

Date publication

janvier 2026

Journal

Lupus science & medicine

Auteurs

Membres identifiés du Cancéropôle Est :
Pr BONNOTTE Bernard

Tous les auteurs :
Sixt T, Lakomy D, Guilloteau A, Samson M, Bonnotte B, Audia S

Lien Pubmed

https://www.ncbi.nlm.nih.gov/pubmed/41526172

Résumé

To assess the clinical relevance of concurrent measurement of anti-chromatin antibodies and anti-double-stranded DNA (anti-dsDNA) antibodies using a multiplex immunoassay in systemic lupus erythematosus (SLE), focusing on their association with organ-specific manifestations and disease activity.